Left Ventricular Systolic Function Is Hyperdynamic

A hyperdynamic left ventricle is one that squeezes more forcefully than expected, typically defined by an ejection fraction above 70%, meaning the heart empties more than 70% of its blood volume with each beat. Most clinicians define a normal ejection fraction somewhere between 50% and 65%, so crossing the 70% threshold puts you well beyond the usual range. What surprises many people is that this seemingly powerful heart performance is not always a sign of cardiac health. Depending on the clinical context, a hyperdynamic left ventricle can reflect anything from a perfectly adapted athlete’s heart during exercise to a dangerously malfunctioning circulatory system in a critically ill patient.

What the Numbers Actually Mean

Ejection fraction describes what fraction of the blood sitting in the left ventricle gets pumped out during each heartbeat. If the ventricle holds 100 mL at its fullest and ejects 60 mL, the ejection fraction is 60%. The threshold for calling left ventricular systolic function “hyperdynamic” is generally an ejection fraction above 70%.¹ That cutoff has been used consistently across intensive care research, including a large study of nearly 2,900 ICU patients in which about 11% met the hyperdynamic definition.²

On the surface, a heart that ejects 75% or 80% of its contents sounds like it should be outperforming a heart at 55%. But the ejection fraction is a ratio, not a direct measure of how much blood reaches the body. A small, under-filled ventricle can produce a very high ejection fraction while actually delivering less blood per minute than a normal heart. This distinction matters enormously in clinical practice.

Why the Heart Goes Hyperdynamic

The underlying physiology involves two broad changes working in tandem: the body’s blood vessels relax and widen (dropping what’s called systemic vascular resistance), and circulating blood volume increases to compensate. The heart responds by beating faster and contracting more vigorously, pushing out a larger share of whatever blood fills the chamber.³ In high-output states, the drop in vascular resistance reduces the resistance the heart pumps against, making each contraction more efficient in a purely mechanical sense. But that low resistance also reduces blood flow to the kidneys, which triggers fluid retention, expanding the circulating volume even further and keeping the cycle going.

This mechanism shows up across a remarkably wide set of clinical conditions. The common thread is anything that dramatically lowers vascular resistance or demands more cardiac output than usual.

Conditions That Trigger Hyperdynamic Function

Sepsis and Systemic Infection

Sepsis is one of the most studied triggers. During a serious infection, inflammatory mediators cause widespread blood vessel dilation, and the heart compensates by pumping harder. In septic shock specifically, the combination of low vascular resistance, elevated heart rate, and sometimes aggressive use of drugs designed to strengthen heart contraction (inotropes) can push the ejection fraction well past 70%.⁴ This is not a sign the heart is thriving; it reflects a circulatory system under severe stress.

Liver Cirrhosis

Advanced liver disease produces its own version of a hyperdynamic circulation, which is considered a hallmark of the condition.⁵ As the liver deteriorates, substances that would normally be cleared by the liver accumulate in the bloodstream and cause blood vessels to dilate. Cardiac output rises in response. This pattern, sometimes called cirrhotic cardiomyopathy, can mask underlying heart muscle dysfunction because the ejection fraction looks reassuringly high even as the heart’s ability to relax and fill properly deteriorates.

Hyperthyroidism

An overactive thyroid gland increases the heart’s metabolic rate and sensitivity to stimulating hormones. The result is a faster heart rate and more forceful contractions. Echocardiography in hyperthyroid patients commonly reveals an elevated ejection fraction driven by this hyperdynamic state.⁶ Over time, though, the filling function of the heart deteriorates because the constantly overworked muscle becomes stiffer, making it harder for blood to enter the chamber between beats.

Chronic Severe Anemia

When the blood carries too few red blood cells, the body compensates by increasing the volume of blood it moves per minute. In patients with chronic severe anemia, echocardiographic studies have shown faster heart rates, lower blood pressure, larger left ventricles, and enhanced contractility compared to people with normal blood counts. Importantly, researchers found no evidence of problems with how the heart fills, and patients had no clinical signs of heart failure, supporting the idea that severe anemia produces genuine systolic hyperfunction rather than a failing heart in disguise.⁷

When Hyperdynamic Is Normal

Not every hyperdynamic ejection fraction signals disease. During vigorous physical exercise, even a healthy heart becomes hyperdynamic by design. In trained athletes, the left ventricle shows dramatic increases in how quickly and completely it empties during exertion. A study of young athletes using nuclear imaging found that resting ejection fraction averaged about 70%, and during peak exercise it climbed to roughly 78%, accompanied by a more than threefold increase in cardiac output.⁸ This increase came mainly from a smaller residual volume in the ventricle at the end of each beat and from a higher heart rate, rather than from the ventricle stretching to hold more blood before pumping.

A study of professional football players similarly found that every player tested showed an appropriate hyperdynamic response during exercise, even though resting ejection fraction averaged a perfectly ordinary 58%.⁹ The key distinction is that in athletes, the hyperdynamic state is transient and exercise-provoked. When the heart remains hyperdynamic at rest without an obvious physiological demand, clinicians start looking for a cause.

The Hidden Problem of Diastolic Dysfunction

One of the most counterintuitive findings in this area is that a heart with a supernormal ejection fraction frequently has trouble relaxing and filling. In a study that compared patients with hyperdynamic hearts to those with normal ejection fractions, roughly 78% of the hyperdynamic group had some form of diastolic dysfunction. Their hearts had thicker walls, larger left atria, slower relaxation, and higher filling pressures.¹⁰ In plain terms, the heart was squeezing powerfully but then struggling to refill for the next beat.

This combination is clinically important because patients with a hyperdynamic ejection fraction who show up with shortness of breath on exertion may have their symptoms dismissed. After all, their systolic function looks excellent on paper. But when clinicians have looked more carefully at these patients, particularly those with a hyperdynamic left ventricle on stress imaging and no evidence of blocked arteries, they’ve found that diastolic dysfunction and heart failure with preserved ejection fraction are often the culprits.¹¹ The lesson here is that a high ejection fraction does not rule out heart failure.

A Supernormal Ejection Fraction and Mortality

The relationship between a very high ejection fraction and survival is one of the more surprising findings in modern cardiology. The assumption for decades was that higher is better, but recent data have complicated that story considerably.

A large study found that people with an ejection fraction above 70% had about a 15% higher adjusted risk of dying from any cause compared to those with an ejection fraction in the 60% to 65% range.¹² That finding held even after accounting for other health conditions. Separately, research from the Swedish Heart Failure Registry found that among heart failure patients, those with supranormal ejection fractions (above roughly 65% depending on the study) had higher raw mortality rates than patients with mildly reduced or preserved ejection fractions. However, once researchers adjusted for age and comorbidities, the mortality gap disappeared, suggesting that the supranormal ejection fraction itself may be more of a marker for being older and sicker than an independent killer.¹³

A similar pattern emerged in a study comparing heart failure patients with supranormal ejection fractions to those with preserved or mildly reduced fractions. The supranormal group had higher unadjusted mortality, but after adjusting for baseline characteristics and echocardiographic parameters, the difference was no longer statistically significant.¹⁴ The researchers concluded that a supranormal ejection fraction may function as a red flag for a distinct clinical profile, one characterized by older age, more concentric remodeling of the heart muscle, and a heavier burden of other diseases, rather than being a direct cause of poor outcomes on its own.

Outflow Tract Obstruction in a Hyperdynamic Heart

One of the most dangerous complications that can arise from a hyperdynamic ventricle is left ventricular outflow tract obstruction. When the ventricle contracts too forcefully, the anterior leaflet of the mitral valve can get pulled toward the outflow tract, partially blocking the path blood takes to leave the heart. This phenomenon, known as systolic anterior motion, creates a mechanical obstruction that can cause sudden drops in blood pressure, worsening of mitral valve leakage, and hemodynamic collapse in severe cases.

This is most famously associated with hypertrophic cardiomyopathy, where a thickened heart wall narrows the outflow tract at baseline. But critically, it also happens in patients with structurally normal hearts when the left ventricle becomes hyperdynamic enough.¹⁵ In the ICU, conditions like hypovolemia, septic shock, and excessive doses of inotropic drugs can all produce enough hyperdynamic contractility to trigger this obstruction in people who have never had a structural heart problem.⁴

The treatment for this situation runs exactly opposite to what you would normally do for a patient in shock. Instead of giving more stimulant drugs to make the heart pump harder, clinicians need to slow the heart down and increase the volume of blood filling it. Case reports describe scenarios in which intravenous fluids alone resolved the obstruction (for example, a patient with dehydration-induced obstruction showing a pressure gradient of 29 mmHg that resolved with fluid resuscitation), and another where stopping the stimulant drug and adding a beta-blocker corrected the obstruction in a patient whose inotrope had driven the gradient to 36 mmHg.¹⁶ Giving the wrong treatment, like more fluid restriction or more inotropes, can be catastrophic.¹⁷

When the Measurement Itself Is Wrong

Sometimes a hyperdynamic ejection fraction on a report is not real but is an artifact of how the measurement was taken. Nuclear imaging techniques that calculate ejection fraction can overestimate the value in patients with small left ventricular cavities. The issue is that the imaging camera cannot sharply resolve the boundaries of a small chamber, particularly when the walls are thick or the heart empties nearly completely. This blurring effect artificially shrinks the estimated residual volume, making the ejection fraction look higher than it truly is.¹⁸

This is particularly relevant for certain populations. Elderly women with conditions like aortic stenosis tend to develop thicker, more concentrically remodeled ventricles with smaller cavities, and multiple studies have shown they demonstrate higher indices of systolic function than men with the same disease.¹⁹ Whether this reflects genuine hypercontractility or a measurement artifact related to chamber geometry (or some combination of both) is a question that has not been fully settled. The practical takeaway is that a single ejection fraction number, especially one that looks unusually high, should be interpreted in the context of the patient’s anatomy, body size, and clinical situation rather than taken at face value.

Pulmonary Hypertension as a Downstream Consequence

A less obvious but clinically significant complication of a hyperdynamic heart is the development of pulmonary hypertension. When the left ventricle pushes out an abnormally large volume of blood, that excess flow has to pass through the lungs first on its way back around the circuit. The increased blood flow through the pulmonary vessels, combined with elevated pressures on the left side of the heart, can trigger remodeling and constriction of pulmonary blood vessels over time. The endothelium, the thin lining of the pulmonary vessels, responds to the mechanical stress by releasing substances that cause the vessels to tighten and thicken.³ This creates a vicious cycle: the high cardiac output damages the pulmonary vasculature, which raises pulmonary pressures, which eventually strains the right side of the heart.

This pathway is one reason why conditions associated with chronic high-output states, such as severe liver cirrhosis or long-standing untreated hyperthyroidism, can eventually lead to right-sided heart failure even though the initial problem was on the left side. The left ventricle itself may look impressively powerful on an echocardiogram while the pulmonary circulation and right ventricle are quietly deteriorating under the strain.

How the ICU Handles a Hyperdynamic Ventricle

In critical care, recognizing a hyperdynamic left ventricle early changes management decisions in ways that can be lifesaving. Bedside echocardiography has become the standard tool for rapid assessment. When a patient in septic shock is not responding to the usual treatment of fluids and vasopressors, an ultrasound showing a nearly obliterating ventricle (one that empties so completely the walls almost touch) immediately raises the question of outflow tract obstruction.

The management principles are counterintuitive for clinicians trained to think of shock as a problem of too little cardiac output. In the hyperdynamic scenario, the heart is contracting too aggressively, and the right response is to fill the ventricle with more fluid so it does not collapse on itself, stop any drugs that stimulate contraction, and if needed, use a beta-blocker to slow things down.¹⁷ Vasopressors that constrict blood vessels (increasing afterload) can also help by making the outflow tract stay open during contraction. The wrong reflex, adding more inotropic stimulation because the patient’s blood pressure is low, can worsen the obstruction and push the patient toward cardiovascular collapse.

This paradox, where treating apparent shock with standard shock therapy makes the patient worse, is one of the reasons point-of-care ultrasound has become so central to modern intensive care. Without directly visualizing what the heart is doing, a clinician relying on blood pressure numbers alone has no way to distinguish a failing heart that needs help contracting from a hyperdynamic heart that needs the opposite.

Drugs and Substances That Can Trigger Hyperdynamic States

Beyond the disease states already mentioned, certain medications and substances can push the left ventricle into a hyperdynamic state. Dobutamine, a drug commonly used in ICUs to boost heart function in patients with cardiogenic shock, is the most well-documented pharmacological trigger. At higher doses, it can overshoot its intended effect and produce the kind of near-complete ventricular emptying that leads to outflow tract obstruction.¹⁷ Other stimulant drugs, including those used for stress testing and certain recreational stimulants, can produce similar effects, particularly in people with preexisting anatomical features like a thickened septum that narrows the outflow tract.

Acute hemorrhage and severe dehydration, while not drugs, deserve mention here because they create the same hemodynamic setup. When the blood volume drops sharply, the ventricle becomes under-filled, and if the body’s natural adrenaline response ramps up contractility at the same time, the combination of a small cavity and vigorous squeezing can trigger outflow obstruction in a patient who has no underlying heart disease at all.⁴

Why the Field Is Rethinking Ejection Fraction Categories

For decades, ejection fraction was treated as a simple spectrum where lower numbers meant worse hearts. The emergence of data showing that very high ejection fractions carry their own set of problems has prompted serious reconsideration. The concept of “heart failure with supranormal ejection fraction” is now being discussed in cardiology literature as a potentially distinct entity, separate from the better-known categories of heart failure with reduced or preserved ejection fraction.

Patients in this category tend to be older, more often female, and more likely to have concentric remodeling of the ventricle, meaning the walls are thicker and the cavity is smaller. Their hearts look powerful on a standard ejection fraction measurement, but the structural changes are associated with stiff, poorly relaxing chambers that generate high filling pressures. The diastolic dysfunction described earlier is not an occasional finding in these patients; it is the norm, present in the vast majority.¹⁰ Whether this group needs its own treatment guidelines and diagnostic criteria is an active area of research, but the growing recognition that a supernormal ejection fraction is not simply the healthy end of a spectrum represents a genuine shift in how cardiologists interpret the numbers they see on echocardiograms every day.